跳至主要内容
临床试验/NL-OMON41474
NL-OMON41474已完成不适用

Comparison of effectiveness of hepatitis B revaccination schemes in healthy non-responders - RESPONSE (Revaccination Hepatitis B prospective trial in non responders)

eids Universitair Medisch Centrum0 个研究点目标入组 480 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • A healthy adult with an anti-HBs< 10 IU/L within 1-3 months after a regular vaccine scheme (0,1,6 months) of 3 intramuscular doses of licensed recombinant vaccine against hepatitis B .

排除标准

  • - age: <18 years, >80 years
  • -immunosuppression by disease (e.g. chronic renal failure, human immunodeficiency virus infection) or by immunosuppressiva
  • -pregnancy
  • - primary immunisation serie: <3 IM vaccines
  • - blood sample positive for HBsAg or anti-HBcore antibodies

研究者

相似试验

Comparison of effectiveness of hepatitis B... | 临床试验